Detalles de la búsqueda
1.
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.
Strahlenther Onkol
; 185(2): 94-100, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19240995
2.
Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
Int J Radiat Oncol Biol Phys
; 67(1): 78-83, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17189064
3.
Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Radiother Oncol
; 83(2): 148-55, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17531904
4.
3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects.
Radiother Oncol
; 78(1): 36-40, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16271410
5.
3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment.
Wien Klin Wochenschr
; 118(7-8): 224-9, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16794760
6.
Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Int J Radiat Oncol Biol Phys
; 62(3): 901-11, 2005 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15936576
7.
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Radiother Oncol
; 74(3): 235-45, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15763303
8.
Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
Radiother Oncol
; 68(3): 269-76, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-13129634
9.
The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial.
Radiother Oncol
; 68(1): 51-9, 2003 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12885452
10.
Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy).
Strahlenther Onkol
; 182(9): 537-42, 2006 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16944376
11.
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
J Clin Oncol
; 24(16): 2513-9, 2006 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16636343
12.
Neoadjuvant hormonal treatment and radiotherapy for prostate cancer.
Oncology
; 65 Suppl 1: 29-33, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12949431
13.
Acute side effects during 3-D-planned conformal radiotherapy of prostate cancer. Differences between patient's self-reported questionnaire and the corresponding doctor's report.
Strahlenther Onkol
; 179(5): 320-7, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12740659
14.
Biochemical response after 3-d conformal radiotherapy of localized prostate cancer to a total dose of 66 gy 4-year results.
Strahlenther Onkol
; 178(10): 542-7, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12386785
15.
Interobserver comparison of CT and MRI-based prostate apex definition. Clinical relevance for conformal radiotherapy treatment planning.
Strahlenther Onkol
; 178(5): 263-8, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12082686
Resultados
1 -
15
de 15
1
Próxima >
>>